Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C
Clinical trial NCT03051100 · COMPLETED
Trial details
- NCT number
- NCT03051100
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-19
- Primary completion
- 2017-06-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.